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Abstract
Motivation: Genomic variant detection from next-generation sequencing has become established
as an extremely important component of research and clinical diagnoses in both cancer and
Mendelian disorders. Insertions and deletions (indels) are a common source of variation and can
frequently impact functionality, thus making their detection vitally important. While substantial
effort has gone into detecting indels from DNA, there is still opportunity for improvement. Further,
detection of indels from RNA-Seq data has largely been an afterthought and offers another critical
area for variant detection.
Results: We present here ABRA2, a redesign of the original ABRA implementation that offers sup-
port for realignment of both RNA and DNA short reads. The process results in improved accuracy
and scalability including support for human whole genomes. Results demonstrate substantial im-
provement in indel detection for a variety of data types, including those that were not previously
supported by ABRA. Further, ABRA2 results in broad improvements to variant calling accuracy
across a wide range of post-processing workflows including whole genomes, targeted exomes and
transcriptome sequencing.
Availability and implementation: ABRA2 is implemented in a combination of Java and C/Cþþ and
is freely available to all from: https://github.com/mozack/abra2.
Contact: parkerjs@email.unc.edu
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
Next generation sequencing (NGS) has become a widely used tool
for a variety of applications. Variant calling has been an area of
great interest in DNA for some time and is of increasing interest in
RNA. One of the first steps in a NGS variant calling pipeline is to
align sequenced reads to a reference genome. Widely used DNA
aligners such as bwa-mem and bowtie2 (Langmead and Salzberg,
2012; Li, 2013) are capable of quickly aligning large numbers of
reads and support gapped alignment, thus allowing identification of
indels. For the sake of speed, these methods do not align each read
exhaustively and may in some cases fail to reveal indels, particularly
at increased indel lengths. Historically, variant callers have relied
upon accurately mapped reads to identify Single Nucleotide
Variants (SNVs) and indels. Instances where the reads are not accur-
ately mapped can confound variant detection.
In recent years, a number of methods have been developed that
offer improved detection of indels in DNA. In some cases, variants
can be successfully identified as long as the reads containing the
variant are mapped to roughly the correct location. The original
ABRA implementation (Mose et al., 2014) used a localized assembly
process to adjust read alignments, thus revealing indels in the align-
ments and improving variant detection in a variety of callers such as
Freebayes (Garrison and Marth, 2012) for calling inherited variants,
and Strelka for somatic calling (Saunders et al., 2012). Recently
developed callers used for inherited variant detection such as
Platypus, GATK-HaplotypeCaller (GATK-HC), Strelka2 and
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Scalpel (DePristo et al., 2011; Kim et al., 2018; Narzisi et al., 2014;
Rimmer et al., 2014) all make use of localized assembly allowing for
detection of indels that may or may not be included in the original
read alignments. Similarly, the recently developed Lancet and
Mutect2 (Cibulskis et al., 2013; Narzisi et al., 2018) make use of
localized assembly for somatic variant calling.
RNA-Seq has proven to be extremely important as a diagnostic
tool allowing for analysis of gene and isoform expression, gene
fusions, transcript splicing, expressed variation and RNA editing. The
presence of splice junctions in RNA necessitated the development of
splice aware aligners. Several RNA-Seq aligners have been developed
that are capable of mapping reads that span splice junctions (Dobin
et al., 2013; Kim et al., 2013, 2015; Wang et al., 2010; Wu et al.,
2016). However, the presence of non-trivial variation can cause
RNA-Seq reads to not entirely align. For example, Sun et al. have
demonstrated that standard RNA-Seq pipelines have difficulty identi-
fying indels of length greater than 2 bases (Sun, 2016). Frequently,
variant calling pipelines that were originally developed for DNA are
modified to handle the syntax for RNA-Seq alignments, but are not
optimized for RNA-Seq. For example, the widely used GATK
(DePristo et al., 2011) requires RNA-Seq read alignments to be bro-
ken into multiple alignments with the splice junctions removed, pro-
ducing DNA-like reads that can then be processed using tools
originally developed for DNA variant calling. Additionally, the
recently developed Transindel (Yang et al., 2018) relies upon
bwa-mem—a DNA aligner—for the initial alignment of reads.
ABRA2 is an update to the original ABRA implementation that
provides splice-aware re-alignment of RNA-Seq data as well as sub-
stantially enhanced computational performance. The improved
alignments produced by ABRA2 enable more accurate variant call-
ing of expressed variants in general, and for indels in particular.
Furthermore, ABRA2 improves upon the original ABRA’s accuracy
on DNA, offers faster run times, and enables enhanced scalability
capable of handling human whole genomes.
2 Algorithm
2.1 Original Abra implementation
Briefly, the original ABRA implementation processes input BAM files
on a localized per region basis. Reads of each region of interest are
extracted and assembled using a deBruijn graph. Assembled contigs
are added to a global pool of contigs. Once assembly is complete
across all regions, all contigs are then aligned to the reference genome
using bwa-mem. Chimeric alignments of a given contig are combined
when the alignments clearly indicate the presence of an indel that can
be simply represented as a single variant. Once all contigs have been
aligned, bwa-mem is again used to map all reads to all contigs. When
a read maps more closely to a contig than the reference, it is updated
to match the contig alignment in the context of the reference.
While this method has proven to be effective in many cases of tar-
geted DNA sequencing such as gene panels and whole exomes, there
are several clear shortcomings. When the total number of contigs
grows large, aligning all reads to all contigs can become prohibitively
slow and in some cases cause bwa-mem to not run to completion.
This causes problems in scalability as well as computational difficul-
ties for noisy samples and samples that diverge substantially from the
reference genome as is the case for many mouse strains. Due to the
scalability problems, large samples such as human whole genomes
typically fail to run to completion. Post processing of chimeric bwa-
mem alignments may work well in the presence of a single, simple iso-
lated indel, but may not properly capture more complex or noisy
events consisting of multiple variants or nearby technical artifacts.
Localized assembly has become widely used in variant calling, but is
computationally expensive and may not always be necessary to iden-
tify pertinent variants resulting in unnecessarily long compute times.
Finally, neither the original ABRA nor bwa-mem account for splicing,
thus rendering the tools suboptimal for RNA-Seq data. We have
developed ABRA2 to ameliorate these issues.
2.2 Realignment
2.2.1 Overview
ABRA2 operates on a per-region basis analyzing windows of size
400 bp with each window overlapping by 200 bp. Either the entire
genome is traversed, or regions of interest can be specified via a bed
file. Contigs are generated for each region of interest and aligned
back to the reference. Reads are then mapped to the generated con-
tigs and updated in cases where an improved alignment is discovered
(Fig. 1).
2.2.2 Contig generation
Candidate contigs representing variation from the reference for a
given region are generated in a variety of ways.
Fig. 1. Overview of ABRA2 workflow. Reads overlapping a genomic window
of 400 bp are extracted. Contigs are generated using a variety of mechanisms
including localized assembly, identification of substantially soft clipped reads,
placement of observed indels in localized reference representations and input
known indels. Reference representations of putative transcripts are generated
using annotated splice junctions as well as unannotated splice junctions
observed in the original read alignments. Contigs are exhaustively mapped
to each transcript/reference representation using semi-global alignment and
the single best alignment is identified. Reads are then aligned back to the con-
tigs using a simple seed and extend approach. If a read unambiguously aligns
more closely to a contig than the reference, then the read alignment is
updated based upon the contig’s alignment to the reference
ABRA2 2967
1. Indels and/or splice junctions observed in the original read align-
ments inserted into a localized reference representation.
2. Sequence extracted from reads containing substantial high qual-
ity soft clipping (15 or more bases). Reads aligning to the same
locus may optionally be merged to form a consensus representa-
tion which may be of benefit in cases of amplicon sequencing.
3. Contig generation via localized assembly (Pevzner et al., 2001)
of reads mapped to the region of interest along with unmapped
reads anchored by their pairs. The assembly is executed when
the fraction of assembly triggering reads exceeds a configurable
fraction of total reads in the region. Assembly triggers include
read pairs with one read unmapped, insertions longer than 15%
of the read length in the original alignments, or the presence of
high quality soft clipped bases longer than 25% of the read
length. In cases where multiple samples are present (including
matched tumor/normal pairs), they are assembled jointly.
4. Known or suspected indels passed in as an input VCF file
inserted into a localized reference representation.
2.2.3 Transcript/Reference representations
All splice junctions with a start or end point within the region of
interest (padded by 2 read lengths on either end) are identified to
create a local set of splice junctions J. These may include annotated
splice junctions as well as splice junctions identified in the input
read alignments. Additionally, splice junctions within a read length
of the start or end point of any member of J are added to J. This step
is repeated a second time, which ultimately has the net effect of
allowing reads that partially overlap the region of interest to span 2
splice junctions outside the region of interest and still map properly.
Once the junctions in J are determined, all possible combinations of
the elements of J are identified recursively. Combinations that do
not contain overlapping splice junctions are considered to be a valid
potential transcript. While identifying all possible combinations of
splice junctions can result in substantially more putative transcripts
than simply utilizing annotated transcripts, this is necessary to en-
able accurate alignment of reads in the presence of alternative tran-
scripts that may not be annotated. Reference representations of each
transcript are generated based upon the input reference genome uti-
lizing the loci of the splice junctions corresponding to the putative
transcript.
2.2.4 Contig alignment
Contigs generated from the previous step are then aligned to the
localized regional representations of the reference using semi-global
alignment with affine gap penalties (Brudno et al., 2003; Gotoh,
1982; Smith and Waterman, 1981). The optimal end to end align-
ment of each contig is identified within the local reference represen-
tation. When multiple putative transcripts are present, each contig is
aligned to each transcript representation and the single highest scor-
ing alignment is selected. The final alignment is modified to include
junctions present in the best localized reference representation.
2.2.5 Read alignment
Reads that do not perfectly match the reference are mapped to each
aligned contig using a simple ungapped seed and extend alignment.
The regional reference representation is hashed into 10-mers which
serve as the seeds. A read is compared to all potential reference posi-
tions with a matching seed with the smallest number of mismatches
indicating the optimal alignment. Unlike the original ABRA imple-
mentation, reads are only remapped to contigs arising from nearby
regions. If a read unambiguously maps to a contig more closely than
the reference, the read is updated using the contig’s alignment in the
context of the reference.
2.3 Variant calling
Included with ABRA2 is a simple somatic indel caller named Cadabra
that is capable of calling somatic indels on ABRA2 realigned BAM
files. Reads that map unambiguously to an indel arising from a contig
are used to gather variant counts. These reads are identified using
SAM tags inserted during realignment. Fisher’s Exact Test is used to
evaluate somatic variant status in a fashion similar to Varscan2
(Koboldt et al., 2012). In the presence of repeats, only reads that span
the full repeat are evaluated (Gymrek et al., 2012). Additional simple
filters are used to filter variants including a read orientation bias filter
similar to that implemented in GATK, a low positional read complex-
ity filter based upon the difference of the max and min starting pos-
ition of a variant in the supporting reads and a filter for variant loci
where a majority of spanning reads have a mapping quality of zero.
Optional variant quality penalties are applied at loci with short tan-
dem repeats and homopolymer runs to accommodate increased errors
that may be caused by slippage during Polymerase Chain Reaction
(PCR) amplification.
3 Results
3.1 Evaluation of somatic DNA variant calling
To assess the performance of ABRA2 on somatic DNA calling we
begin with a simulated matched tumor/normal exome dataset. To
create a challenging dataset, 665 SNVs and 1092 indels were spiked
in at variant allele frequencies of 10, 25 and 50%, and indel lengths
ranging from 1 to 100 bp with a median length of 31 bp. Variants
were called using Mutect2 and Strelka2, both with and without
ABRA2 alignments. Lancet variants were called without ABRA2.
ABRA2 has a small effect on SNV detection (Fig. 2a) and enables
Fig. 2. Evaluation of somatic variant calling in DNA. (a) Precision and recall of
somatic SNV detection on a challenging simulated exome dataset containing
insertions and deletions ranging in length from 1 to 100 bp and variant allele
frequency ranging from 10 to 50%. Strelka2, Strelka2/Manta, Mutect2 and
Lancet are evaluated with Strelka2 and Mutect2 also applied to ABRA2
realignments. (b) Precision and recall of somatic indel detection on the exome
dataset. In addition to the SNV callers, Cadabra is applied to the ABRA2
realignments. Pipelines including ABRA2 produce the best overall results. (c)
Somatic SNV calling on the ICGC Dream Somatic Mutation Calling Challenge
5 dataset. Strelka2, Mutect2 and Lancet are evaluated with Strelka2 and
Mutect2 also applied to ABRA2 realignments. (d) Somatic indel calling on the
ICGC Dream Somatic Mutation Calling Challenge 5 dataset. In addition to the
SNV callers, Cadabra is applied to the ABRA2 realignments. ABRA2 com-
bined with Cadabra or Strelka2 produces the best overall results
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a substantial improvement in indel detection (Fig. 2d). The
CadabraþABRA2 combination produces superior accuracy to all
other methods. Mutect2 and Strelka2 show a substantial improve-
ment in accuracy when using ABRA2 realignments compared to
Mutect2 alone and Strelka2 run in conjunction with Manta (Chen
et al., 2016). Notably, the three ABRA2 cases show improved indel
detection accuracy compared to all other methods, with Lancet as
the next best performing method. Compared to the original ABRA
implementation, ABRA2 provides increased sensitivity for indel de-
tection on this dataset (Supplementary Fig. S1). The ABRA2 runtime
on this dataset was 39 min using 8 cores compared to 1 h 45 min for
the original ABRA.
We also assessed the performance of ABRA2 on this dataset
both with and without assembly. Notably, high accuracy is achiev-
able without utilizing localized assembly although assembly does
offer a boost in recall for longer insertions. The version of ABRA2
run with localized assembly disabled detected 17 fewer insertions
with a median length of 60 nucleotides. All other variants were de-
tectable without the use of assembly (Supplementary Fig. S2). The
runtime for ABRA2 with localized assembly disabled was 32 min.
By contrast, when assembly is forced to execute across all target
regions, the ABRA2 runtime was 610 min. This assemble all regions
approach detected no additional variants detected compared to
ABRA2 run with selective assembly. While localized assembly can
be beneficial for variant detection, from a computational perform-
ance standpoint it can be helpful to perform this step selectively.
We assessed the impact of utilizing known indels on this dataset
by running ABRA2 with the truth set of indels passed as candidate
loci to the realigner. As expected, we observed improved accuracy
when utilizing known indel information and most calls revealed by
using known indels as input are longer insertions (median 49 bases)
(Supplementary Fig. S3). A majority of these calls are local repeats
(26 out of 31). Local repeats are likely to map to the region of inter-
est, but can confound assembly due to cycles in the graph. An add-
itional 52 long insertions (median length 61.5) of the correct length
and position were called after realignment with known indels, but
not at nucleotide resolution. Over 90% of these calls were insertions
of sequence arising from a distant location of the genome (i.e. mo-
bile insertions). By comparison, there were eight true positive calls
not at nucleotide resolution in the ABRA2 de novo dataset all of
which are mobile insertions. In contrast with local repeats, reads
that span a mobile insertion with a length greater than half of the
read length are likely to align elsewhere in the genome resulting in
no reads spanning the full insertion in the region of interest, thus
causing difficulty in variant identification for localized processing.
All non-nucleotide resolution calls were filtered from the result set
in the precision/recall plots.
We also evaluated ABRA2 on the somatic whole genome ICGC-
TCGA-DREAM Somatic Mutation Calling Challenge #5 dataset
(Ewing et al., 2015). As with the exome dataset, ABRA2 has min-
imal impact on SNV detection (Fig. 2c). Indel sizes on this dataset
are generally smaller with a median length of 7 bp and as a result re-
call is higher among all methods (Fig. 2d). CadabraþABRA2 and
Strelka2þABRA2 are the top performers in this dataset with
ABRA2 enabling a marked improvement in recall.
3.2 Evaluation of RNA-Seq variant calling
ABRA2’s impact on variant calling on RNA-Seq data was evaluated
using two sets of reads generated using the BEERs simulation engine
(Grant et al., 2011). We modified BEERs to generate reads contain-
ing indels of length 1–19 bp for a dataset of moderate difficulty and
1–75 bp for a more challenging dataset. Variants were called using
Freebayes, GATK-HC and Strelka2 in germline mode, both with
and without ABRA2 run on STAR alignments. Transindel was run
against the STAR alignments and GATK-HC was additionally run
against GSNAP alignments (Wu et al., 2016). On the moderate data-
set, ABRA2 enables improvements for Freebayes, Strelka2 and
GATK-HC in SNP detection (Fig. 3a). For indels, a clear improve-
ment in recall is observed in the ABRA2 realignments for Freebayes,
Strelka2 and GATK-HC (Fig. 3b). On the challenging dataset,
ABRA2 results in substantial improvements in SNP detection for
both GATK-HC and Freebayes as well as a noticeable improvement
for Strelka2 (Fig. 3c). The improvement in SNP detection accuracy
in many cases was due to misalignments where the longer indel
lengths cause problems for the variant callers in the non-ABRA2
cases. For indels, the 3 ABRA2 configurations yield the best results
along with Strelka2 (Fig. 3d).
3.3 Genome in a bottle assessment
We next evaluated ABRA2’s performance using Genome in a Bottle
(GIAB) (Zook et al., 2016) data for subject NA12878. Genotypes
were called using Freebayes, Strelka2 and GATK-HC both with and
without ABRA2 on a whole genome dataset. ABRA2 has little im-
pact on SNP detection across the three methods (Fig. 4a). For indels,
ABRA2 enables a clear improvement in Freebayes accuracy, and has
a small impact on GATK-HC and Strelka2 (Fig. 4b). We additional-
ly acquired RNA-Seq reads for the same subject from Gene
Expression Omnibus (Sample GSM2308414) (The ENCODE
Project Consortium, 2012) for evaluation. Variants were called
using Freebayes, Strelka2 and GATK-HC both with and without
ABRA2. TransIndel was also used for variant calling without
Fig. 3. Evaluation of RNA-Seq variant calling. (a) Precision and recall of RNA-
Seq variant calling for SNPs on a simulated dataset of moderate difficulty
containing indels ranging in length from 1 to 19 bp. Freebayes, Strelka2 and
GATK-HaplotypeCaller (GATK-HC) are used in this evaluation. Freebayes,
Strelka2 and GATK-HC are run with and without ABRA2 on STAR alignments.
GATK-HC is also run on GSNAP alignments and Transindel is run on bwa-
mem alignments. ABRA2 results in improvements for Freebayes, Strelka2
and GATK-HC in RNA SNP detection. (b) Precision and recall of RNA-Seq vari-
ant calling for indels on the moderate difficulty RNA-Seq dataset. A clear im-
provement in accuracy is observed in the ABRA2 realignments for Strelka2,
Freebayes and GATK-HC. (c) Precision and recall of RNA-Seq variant calling
for SNPs on a more challenging dataset containing indels ranging in length
from 1 to 75 bp. ABRA2 results in substantial improvements in SNP detection
for both GATK-HC and Freebayes with improvements for Strelka2 also
observed. (d) Precision and recall of RNA-Seq variant calling for indels on the
challenging dataset. Here, the 3 ABRA2 pipelines produce the best results
along with Strelka2
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ABRA2. In the absence of ground truth specifically in the context of
RNA-Seq, we report the number of called alleles that are concordant
and discordant with the GIAB whole genome truth set. Among unfil-
tered calls, SNPs that fit the profile of A-to-I RNA editing dominate
the discordant call set with C-to-U calls also being somewhat ele-
vated. By contrast, the transition/transversion ratio for the concord-
ant SNPs is 2.2 (Supplementary Fig. S4b, c). To address the impact
of these potential RNA edits on the discordant calls, SNPs found in
the Rigorously Annotated Database of A-to-I RNA Editing
(RADAR) (Ramaswami and Li, 2014) were filtered which resulted
in a substantial reduction of discordant calls (i.e. 79% of discordant
A-to-I calls were removed for ABRA2þFreebayes at QUAL 30 and a
total of 8 concordant calls were removed) (Supplementary Fig. S4a).
ABRA2 has a small impact on SNP detection in this dataset
(Fig. 4c), and enables a substantive improvement in overall perform-
ance in indel detection for both Freebayes and Strelka2 with an in-
crease in concordant calls also observed in GATK-HC (Fig. 4d).
3.4 EGFR deletions in TCGA lung adenocarcinoma
Deletions in Epidermal Growth Factor Receptor (EGFR) exon 19
have oncogenic potential and can be indicators for treatment with
Gefitinib or Erlotinib, making accurate detection of these variants
clinically vital. Deletions ranging in length from 9 to 24 bp were
detected in 23 samples of the TCGA Lung Adenocarcinoma (LUAD)
cohort using matched tumor/normal DNA samples (The Cancer
Genome Atlas Network, 2014). Additionally, Ye et al. identified 8
complex indels (Ye et al., 2016) in the same cohort with 3 overlap-
ping the TCGA set for a total of 28 cases, of which 27 have available
RNA-Seq data. We attempted here to detect these deletions from
RNA-Seq alone. Variant calling pipelines were run as described in
the GIAB RNA-Seq experiment. GATK-HC, Freebayes and Strelka2
detect 1, 0 and 9 deletions respectively without ABRA2. Using the
ABRA2 alignments, all callers detect all 27 deletions (Fig. 5a). Non-
trivial variants in this exon prove to be particularly difficult to ac-
curately identify due to nearby introns (Fig. 5c–d).
3.5 Clinically validated indels
RNA sequencing was performed on 67 subjects that were previously
found to harbor 88 coding indels in cancer genes via DNA matched
tumor/normal sequencing as part of the UNCSeq project (Jeck et al.,
2014; Patel et al., 2018). These 88 variants were all confirmed as
part of standard of care molecular testing in the Molecular
Pathology and Genetics laboratory at UNC Medical Center. Variant
calling pipelines on RNA-Seq data for these 67 subjects were run as
previously described. ABRA2 increases the number of these clinical-
ly confirmed indels detected from RNA-Seq alone across all three
variant callers (Fig. 5b).
3.6 TCGA breast and lung adenocarcinoma
We used ABRA2 and Cadabra to detect somatic indels in 1068
TCGA Breast (BRCA) and 506 Lung Adenocarcinoma (LUAD) sub-
jects with matched tumor/normal DNA and tumor RNA (The
Cancer Genome Atlas Network, 2012; The Cancer Genome Atlas
Research Network, 2014). We additionally ran ABRA2 and
Cadabra on 98 whole genome tumor/normal DNA pairs in the
BRCA cohort.
954 and 473 subjects contained at least one somatic protein cod-
ing indel in the BRCA and LUAD cohorts respectively. Detected
deletions ranged in size from 1 to 461 bases with a 75th percentile
of 9 bases, while insertions ranged in size from 1 to 242 bases with a
75th percentile of 3 bases. In the BRCA cohort GATA3, TP53,
CDH1 and MAP3K1 contained somatic indels in more than 5% of
subjects (106, 84, 80 and 55 subjects respectively). Evidence of ex-
pression of the indel mutations for each of these genes is present in
85% of subjects or more (94, 89, 85, 95%) (Fig. 6a). In the LUAD
cohort, somatic indels were detected in TP53 and EGFR in more
than 5% of samples (37 and 33 subjects respectively). 84% of the
TP53 indels were expressed and 100% of the EGFR indels were
expressed (Fig. 6b). More generally, genes previously identified as
Fig. 4. Genome in a bottle assessment. (a) Precision and recall of whole genome
DNA germline SNP variant calling on the Genome in a Bottle dataset. Freebayes,
Strelka2 and GATK-HC were run with and without ABRA2. (b) Precision and re-
call of whole genome DNA germline indel variant calling on the Genome in a
Bottle dataset. ABRA2 improves accuracy for Freebayes and has a small impact
on Strelka2 and GATK-HC. (c) Evaluation of RNA-Seq SNP variant calling on the
Genome in a Bottle dataset. In the absence of ground truth for RNA-Seq, we re-
port counts of calls concordant and discordant with the Genome in a Bottle truth
set. Strelka2, Freebayes and GATK-HC were run with and without ABRA2 while
TransIndel was run without ABRA2 only. (d) Evaluation of RNA-Seq indel variant
calling on the Genome in a Bottle dataset. ABRA2 improves overall performance
for both Freebayes and Strelka2 as well as recall for GATK-HC with the
ABRA2þFreebayes combination achieving the highest accuracy
Fig. 5. TCGA LUAD EGFR deletions and cancer gene panel clinical validation.
(a) Number of clinically actionable TCGA EGFR exon 19 indels detected from
RNA alone by GATK-HC, Freebayes and Strelka2. All callers were run both
with and without ABRA2. ABRA2 enabled detection of all 27 deletions that
were originally detected in DNA by each of the evaluated callers. (b) Number
of clinically validated indels from the UNCSeq project detected from RNA
alone. ABRA2 increases the number of indels detected in RNA by Freebayes,
GATK-HC and Strelka2. (c) STAR alignments of a complex EGFR variant
flanked by introns. Reads containing the variant are soft clipped and the
alignments do not accurately reflect the variant. (d) Complex EGFR variant
flanked by introns and revealed by ABRA2
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significantly mutated in the TCGA studies were more likely to ex-
hibit increased variant allele frequency (Fig. 6b, d) of indels.
Notably, 100% of the LUAD EGFR indels are in frame whereas
84% of the LUAD TP53 indels are frameshift variants. Additionally,
elevated gene expression levels were observed in the LUAD EGFR
indel mutated samples suggesting possible oncogenic activity
(Fig. 6e). By contrast, TP53 gene expression was reduced in LUAD
TP53 indel mutated subjects indicating a possible disruption of
tumor suppression activity (Fig. 6f).
For these TCGA datasets, ABRA2 was run using 16 cores for
WXS and RNA-Seq processing. Median runtimes for WXS tumor/
normal joint realignment and RNA-Seq realignment were 40 min
and 5.1 h and RAM usage was roughly 16GB and 24GB respective-
ly. WGS tumor/normal pairs were realigned using 32 cores with a
median runtime of 15.5 h using 60GB of RAM or less.
4 Discussion
Variant detection and identification of indels are important for both
research and clinical diagnoses in a variety of areas including Cancer
and Mendelian disorders. The ability to accurately identify indels in
DNA has been an area of focus by multiple groups and good pro-
gress has been made. Detecting variants that have been expressed in
RNA-Seq enables greater insight into function. In the context of can-
cer diagnoses and research, detecting expressed mutations has the
potential of enabling better understanding of mutations with onco-
genic potential, identification of neoantigens and potential assess-
ment of mutational burden.
ABRA2 improves upon the original ABRA implementation
enabling increased accuracy of indel detection in DNA via
realignment of NGS reads. ABRA2 additionally improves upon
ABRA in the areas of speed and scalability. ABRA2 was designed
with RNA-Seq in mind and does not require special processing to
treat RNA-Seq data as if it were DNA. By directly making use of
splice junction information, ABRA2 is able to achieve greatly
improved accuracy over other methods. Alignment of each contig to
each putative transcript is currently the computational bottleneck
for ABRA2 and we believe this coud potentially be optimized by
using a graph representation (Garrison et al., 2018; Paten et al.,
2017) for contig alignment instead of distinct linear representations
of each transcript.
ABRA2 can also be used to realign individual samples or mul-
tiple samples jointly such as in the case of matched tumor/normal
pairs. Indels identified in DNA can optionally be used to inform
RNA alignments although RNA can also be processed independent-
ly. As we have shown in several assessments on both real and
simulated data, ABRA2 can be used to improve alignments in a var-
iety of scenarios including both germline and somatic variant calling
as well as targeted sequencing, whole genomes and transcriptomes.
The improved alignments produced by ABRA2 enhance variant de-
tection by a variety of downstream tools with substantial improve-
ment demonstrated for indel detection in both DNA and RNA. This
method should lead to the identification of additional patients with
previously undetected somatic mutations and indels as well as
improving assessment of expressed variants, thus leading to
improvements in patient care and precision medicine.
5 Methods
5.1 Exome simulation
To generate DNA exome simulated data, trimmed fastq files for sub-
ject NA12878 were downloaded from: ftp://ftp-trace.ncbi.nih.gov/giab/
ftp/data/NA12878/Garvan_NA12878_HG001_HiSeq_Exome.
Bamsurgeon (Ewing et al., 2015) was used to insert SNVs and indels
into exome targeted reads. The output of Bamsurgeon is a normal
BAM without the simulated variants and a tumor BAM containing the
simulated variants. Inserted sequences include repeats, mobile elements
and randomly generated sequence. Indel sizes range from 1 to 100 bp.
5.2 RNA-Seq simulation
Simulated RNA-Seq data were generated using the BEERs simula-
tion engine. We modified BEERs to generate reads containing indels
of length 1–19 bp for a dataset of moderate difficulty and 1–75 bp
for a more challenging dataset. For the challenging dataset, the
STAR aligner was configured to use a minimum intron length of 76.
5.3 Read prep and alignment
Initial DNA alignments were performed using bwa-mem version
0.7.9a and 0.7.16a. RNA-Seq alignments were performed using STAR
version 2.5.3 in two pass mode with unmapped reads included in the
output and Gencode annotations provided to the aligner. Parameters
outFilterScoreMinOverLread and outFilterMatchNminOverLread
were set to .45, which allows STAR to align only one end of a read
pair when alignment for both ends is not possible. STAR output was
post-processed to assign unmapped reads to the locus of its mapped
mate when applicable as is the recommended practice per the
Sequence Alignment/Map Format Specification (https://samtools.
github.io/hts-specs/SAMv1.pdf). For the challenging RNA simulation,
alignIntronMin is set to 76. When applicable, STAR was run separate-
ly with outSAMmapqUnique set to 60 which was required to allow
processing by the GATK. GSNAP version 2017-11-15 is additionally
Fig. 6. TCGA breast and lung adenocarcinoma indels. (a) Frequency of genes
harboring somatic coding indels in the TCGA BRCA cohort with evidence of
expression of the indel mutation. Frequency is computed by simple counts of
subjects containing coding mutations and does not take into account exon
lengths of each gene. (b) Comparison of RNA Variant Allele Frequency (VAF)
of coding indels between genes previously identified as ‘significantly
mutated’ (SMG) and not significantly mutated (non-SMG) in the BRCA cohort.
(c) Frequency of genes harboring somatic coding indels in the TCGA LUAD
cohort with evidence of expression of the indel mutation. (d) Comparison of
RNA VAF of coding indels between genes previously identified as ‘significant-
ly mutated’ and not significantly mutated in the LUAD cohort. (e) EGFR gene
expression for tumor RNA samples containing an EGFR coding indel versus
those without an EGFR coding indel in the TCGA LUAD cohort. EGFR is more
highly expressed in samples containing an indel. (f) TP53 gene expression for
tumor RNA samples containing a TP53 coding indel versus those without a
TP53 indel in the TCGA LUAD cohort. TP53 expression is lower in samples
containing an indel
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used for comparison purposes in the RNA simulations. Prior to align-
ment, read trimming for TCGA DNA reads was performed using
SeqPurge version 0.1-874-g426ed18 (Sturm et al., 2016). Duplicates
were marked using either biobambam (Tischler and Leonard, 2014)
or Picard Tools.
5.4 Realignment with ABRA2
Realignments were performed using ABRA2 version 2.14 for most
cases, with versions 2.11 and 2.12 also used for TCGA whole gen-
ome processing. In all cases the –undup flag was set, allowing reads
erroneously marked as duplicates to be rescued in cases where one
end of a read pair is initially mapped and both ends are mapped
post-ABRA2. This requires that duplicate marking be re-run post
ABRA2. For somatic cases, the tumor and normal are realigned to-
gether. For whole genomes, regions of abnormally high depth with a
read count greater than 2000 were skipped. Gencode annotations
and splice junctions identified in the original alignments were used
to inform ABRA2 of potential junctions during RNA-Seq realign-
ment. The maximum distance to move reads was increased to
5 00 000 and unmapped reads were not utilized in assembly. Reads
containing indels abutting splice junctions were filtered as necessary
to allow downstream variant callers to run to completion. For the
TCGA analysis, somatic indels identified in DNA were used to in-
form the RNA-Seq ABRA2 realignments. Known indels were not
utilized in any of the other analyses with the exception of the known
indel assessment on the exome simulation.
5.5 Variant calling
Evaluated variant caller versions are Strelka2 (version 2.9.2), Freebayes
(commit c15b070639d54d112988946a6902d945357e40f0), GATK
HaplotypeCaller and Mutect2 (version 4.0.3.0), Lancet (version 1.0.1),
Manta (version 1.2.2) and TransIndel (version 0.1). For RNA-Seq vari-
ant calling with GATK Haplotyper, the GATK version at git commit
8103bde7ef90c22e66f9f639809cc91122928ffd was used. In general,
default settings are used with a few exceptions. On the exome simula-
tions, Strelka2 maxIndelSize was set to 100. Short Tandem Repeat pen-
alties were disabled for Cadabra on the Dream Challenge dataset.
Lancet calls filtered by only the StrandBias filter are converted to PASS
which appears to produce improved results on the simulated datasets
as was also observed in Narzisi et al. For the GIAB RNA-Seq analyses,
SNPs found in the RADAR database were filtered. RADAR version 2
was used and ‘lifted over’ from hg19 to hg38 (Kent et al., 2002). For
the TCGA analysis, DNA indels were called using Cadabra and RNA
indel calling was performed independently using a beta binomial test
based upon the UNCeqR implementation (Wilkerson et al., 2014).
Variants arising from low complexity regions were filtered as described
by Li (2014). Variant calls were annotated using VEP (McLaren et al.,
2016). For each variant caller, a single metric was used for thresholding
values in the precision/recall plots. For Mutect2 the TLOD score was
used. For somatic Strelka2 the QSS_NT and QSI_NT scores were used
for SNVs and indels respectively. For Cadabra, Lancet, Freebayes,
GATK-HC and germline Strelka2 the QUAL score was used.
TransIndel did not provide a statistic indicating variant call quality and
we used a single point to reflect its performance.
5.6 Variant calling evaluation
Variant calls were evaluated using happy (https://github.com/Illumina/
hap.py) combined with RTG Tools (https://github.com/RealTime
Genomics/rtg-tools) for the GIAB datasets. The default behavior of
hap.py is to assess genotype accuracy. For the GIAB RNA-Seq dataset,
we instead use the allele match method described by Krusche et al.
(2018). All other datasets were evaluated using RTG Tools.
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